Paid Clinical Trials Wichita
Discover 126 paid clinical trials in Wichita, Kansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
VITRAKVIStudy to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body
Sponsor:
Bayer
Location:
Code:
NCT04142437
Conditions
Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
larotrectinib(Vitrakvi, BAY2757556)
Observational StudyAn INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY to ASSESS the PERFORMANCE of the CORDIO HEARO SYSTEM
Sponsor:
Cordio Medical
Location:
Code:
NCT06378632
Conditions
Heart Failure
Eligibility Criteria
Sex: All
Age: 22+
Healthy Volunteers: Not accepted
Interventions
Hearo App
ADSTILADRINADSTILADRIN Early Utilization and Outcomes in the Real World Setting
Sponsor:
Ferring Pharmaceuticals
Location:
Code:
NCT06026332
Conditions
Bladder Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
ADSTILADRIN
Trastuzumab Deruxtecan & AnastrozoleTrastuzumab Deruxtecan Alone or in Combination with Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
Sponsor:
Jonsson Comprehensive Cancer Center
Location:
Code:
NCT04553770
Conditions
Early-stage Breast Cancer
Hormone Receptor Positive Breast Carcinoma
Invasive Breast Cancer
Stage II Breast Cancer
Stage IIA Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Anastrozole
Therapeutic Conventional Surgery
Trastuzumab Deruxtecan
Diuretics vs. AortixDiuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Sponsor:
Procyrion
Location:
Code:
NCT05677100
Conditions
Heart Failure
Cardiorenal Syndrome
Cardio-Renal Syndrome
ADHF
Heart Failure, Systolic
Eligibility Criteria
Sex: All
Age: 21+
Healthy Volunteers: Not accepted
Interventions
Aortix System
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Radiofrequency SUIProspective US Radiofrequency SUI Trial
Sponsor:
Viveve Inc.
Location:
Code:
NCT04720352
Conditions
Urinary Incontinence, Stress
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Active treatment
Sham
eCoinA Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)
Sponsor:
Valencia Technologies Corporation
Location:
Code:
NCT05685433
Conditions
Overactive Bladder
Urge Incontinence
Incontinence, Urinary
Urinary Urge Incontinence
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
eCoin Tibial Nerve Stimulation
TAR-200 vs. Intravesical ChemotherapyA Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG)
Sponsor:
Janssen Research & Development, LLC
Location:
Code:
NCT06211764
Conditions
Non-Muscle Invasive Bladder Neoplasms
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
TAR-200
Mitomycin C
Gemcitabine
Observational StudyComputer-Based Continuing Education for Doctors in Examination and Counseling of Patients on Skin Cancer or Weight Control
Sponsor:
Rhode Island Hospital
Location:
Code:
NCT00295906
Conditions
Melanoma (Skin)
Non-melanomatous Skin Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
educational intervention
internet-based intervention